Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D003687 |
Dehydroepiandrosterone |
Dehydroepiandrosterone results in increased expression of TYK2 mRNA | increases expression | 18709148
|
D004958 |
Estradiol |
Estradiol results in increased expression of TYK2 mRNA | increases expression | 18709148
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TYK2 mRNA | affects cotreatment|increases expression | 17942748
|
D008727 |
Methotrexate |
TYK2 protein affects the susceptibility to Methotrexate | affects response to substance | 16217747
|
D037742 |
Nanotubes, Carbon |
Nanotubes, Carbon results in decreased expression of TYK2 mRNA | decreases expression | 15585362
|
C023036 |
perfluorooctanoic acid |
perfluorooctanoic acid results in increased expression of TYK2 mRNA | increases expression | 18709148
|
C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of TYK2 mRNA | decreases expression | 12760830
|
D013654 |
Taurine |
Taurine results in decreased expression of TYK2 mRNA | decreases expression | 16579726
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TYK2 mRNA | affects cotreatment|increases expression | 17942748
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Methotrexate |
9.56 | 12039119 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
9.56 | 14514962 15322242 11752688 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.26 | 17505938 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
4.37 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
4.37 | 14692618 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.66 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
5.02 | 15276417 |
MESH:D000309 |
Adrenal Insufficiency |
|
Dehydroepiandrosterone |
6.02 | 17302879 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
5.22 | 17306315 16712894 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.14 | 11748828 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.72 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.78 | 15885639 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Methotrexate |
3.14 | 17286800 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.25 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.11 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.89 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
1.93 | 17289903 18497071 17261762 16675129 17018787 14630087 19861407 12948864 |
MESH:D001943 |
Breast Neoplasms |
|
Methotrexate |
1.93 | 16978400 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.93 | 20435547 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.75 | 16111702 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.96 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
3.12 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
3.12 | 15276417 17306315 16507464 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
2.43 | 18572023 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.47 | 18670907 16120746 18850075 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
7.20 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
7.20 | 19524636 20056578 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.34 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
3.02 | 11677210 17681005 16919318 17110522 17333356 15861022 16105132 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.18 | 16354765 8697196 15340226 12621046 15668235 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.24 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Methotrexate |
2.80 | 9562676 12039119 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.80 | 15322242 20055451 10048152 |
MESH:D003424 |
Crohn Disease |
marker/mechanism |
|
| 21102463 |
MESH:D003550 |
Cystic Fibrosis |
|
Methotrexate |
4.43 | 19747007 |
MESH:D003882 |
Dermatomyositis |
|
Methotrexate |
5.36 | 20191521 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Dehydroepiandrosterone |
3.75 | 16616286 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.71 | 17107852 |
MESH:D058065 |
Diabetic Cardiomyopathies |
|
Taurine |
6.34 | 16025228 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.59 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Taurine |
4.45 | 9328219 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
4.45 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.91 | 11462148 |
MESH:D004487 |
Edema |
|
perfluorooctanoic acid |
7.63 | 17259670 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
7.63 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.22 | 18230668 15322242 16714409 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
3.42 | 12538720 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
3.11 | 11473722 18566989 19148513 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.21 | 10568697 9294722 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.16 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
3.02 | 15345470 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.71 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
3.21 | 20067830 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.96 | 16452187 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.91 | 10696789 |
MESH:D006086 |
Graft vs Host Disease |
|
Methotrexate |
5.41 | 16518429 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.43 | 11294989 10048152 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.54 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
perfluorooctanoic acid |
9.54 | 3609246 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
9.54 | 12621046 15340226 16120746 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
5.35 | 15709030 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.33 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
4.07 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.36 | 8697196 18606429 15340226 16354765 16959395 |
MESH:D006930 |
Hyperalgesia |
|
perfluorooctanoic acid |
4.01 | 12083418 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.97 | 18850075 18670907 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
4.07 | 16569931 16945680 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.68 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
7.08 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
7.08 | 12646999 15346721 |
MESH:D007249 |
Inflammation |
|
perfluorooctanoic acid |
5.47 | 12083418 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.47 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
3.09 | 16393666 16627594 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.54 | 16580747 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
6.47 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
6.47 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
3.15 | 15610895 |
MESH:D007805 |
Language Development Disorders |
|
Methotrexate |
5.32 | 9562676 |
MESH:D007984 |
Leydig Cell Tumor |
|
perfluorooctanoic acid |
5.51 | 8812269 |
MESH:D008103 |
Liver Cirrhosis |
|
Methotrexate |
3.80 | 14986274 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
3.75 | 14659978 14716833 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Taurine |
3.75 | 15893842 15931870 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.75 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
Dehydroepiandrosterone |
11.37 | 18709148 |
MESH:D008113 |
Liver Neoplasms |
|
perfluorooctanoic acid |
11.37 | 14757943 18709148 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
11.37 | 15276417 16712894 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
11.37 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Dehydroepiandrosterone |
6.62 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
6.62 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.30 | 19095001 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Methotrexate |
5.34 | 18516814 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
2.35 | 17306315 19931552 15276417 16712894 17077188 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.35 | 11884234 19555203 |
MESH:D008223 |
Lymphoma |
|
Methotrexate |
4.09 | 17352296 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Dehydroepiandrosterone |
6.85 | 16457693 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
6.85 | 16891317 17203775 11408345 11807958 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.80 | 19453300 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
2.05 | 19082730 16487513 |
MESH:D052016 |
Mucositis |
|
Methotrexate |
5.57 | 17488658 |
MESH:D009103 |
Multiple Sclerosis |
marker/mechanism |
|
| 19525955 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.18 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
3.44 | 16810080 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
2.58 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.92 | 20056578 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
4.02 | 17289903 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
10.27 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
10.27 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
3.27 | 12854658 |
MESH:D052556 |
Niemann-Pick Disease, Type C |
|
perfluorooctanoic acid |
5.21 | 9802331 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Dehydroepiandrosterone |
5.25 | 16397352 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
5.02 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
5.02 | 15276417 17306315 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.91 | 11578682 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.57 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.80 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
perfluorooctanoic acid |
10.64 | 17132714 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
10.64 | 11222880 11896295 11118676 11399792 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
4.09 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
3.18 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
3.18 | 16039940 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.60 | 16919318 15861022 |
MESH:D011565 |
Psoriasis |
marker/mechanism |
|
| 20953190 |
MESH:D011565 |
Psoriasis |
|
Methotrexate |
3.49 | 17410198 |
MESH:D051437 |
Renal Insufficiency |
|
Methotrexate |
4.97 | 17352296 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.08 | 18990726 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
5.88 | 19524636 18572023 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.88 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
4.26 | 16709447 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.95 | 12854658 |
MESH:D013576 |
Syndactyly |
|
Methotrexate |
5.27 | 9562676 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.84 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.33 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.22 | 12697716 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
5.00 | 19048282 |
OMIM:611521 |
TYROSINE KINASE 2 DEFICIENCY |
marker/mechanism |
|
| |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
2.57 | 11723127 17306315 16712894 16452187 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
3.96 | 11813266 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.54 | 14692618 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.71 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.91 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.75 | 14671159 15869587 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.57 | 15886252 |